{"id":1929,"date":"2017-07-31T17:43:14","date_gmt":"2017-07-31T17:43:14","guid":{"rendered":"http:\/\/cytologystuff1.wpengine.com\/gyn-atlas-table-of-contents\/other-malignant-neoplasms-including-extrauterine-malignancies\/"},"modified":"2018-03-16T05:11:37","modified_gmt":"2018-03-16T05:11:37","slug":"other-malignant-neoplasms-including-extrauterine-malignancies","status":"publish","type":"page","link":"https:\/\/dev.cytologystuff.com\/fr\/gyn-atlas-table-of-contents\/other-malignant-neoplasms-including-extrauterine-malignancies\/","title":{"rendered":"AUTRES N\u00c9OPLASMES MALINS, NOTAMMENT TUMEURS EXTRA-UT\u00c9RINES"},"content":{"rendered":"

[vc_row 0=””][vc_column 0=”” offset=”vc_hidden-lg vc_hidden-md”][vc_raw_html 0=””]PGNlbnRlcj48YSBjbGFzcz0ic2hpZnRuYXYtdG9nZ2xlIHNoaWZ0bmF2LXRvZ2dsZS1idXR0b24iIGRhdGEtc2hpZnRuYXYtdGFyZ2V0PSJzaGlmdG5hdi1tYWluIj48aSBjbGFzcz0iZmEgZmEtYmFycyI+PC9pPiBUYWJsZSBvZiBDb250ZW50cyA8L2E+PC9jZW50ZXI+[\/vc_raw_html][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=”AUTRES N\u00c9OPLASMES MALINS, NOTAMMENT TUMEURS EXTRA-UT\u00c9RINES” font_container=”tag:h1|text_align:center” use_theme_fonts=”yes”][\/vc_column][\/vc_row][vc_row][vc_column width=”2\/3″][vc_column_text]AUTRES N\u00c9OPLASMES MALINS, NOTAMMENT TUMEURS EXTRA-UT\u00c9RINES
\nMartha L. Hutchinson, MD, PhD <\/em><\/p>\n

Les tumeurs malignes p\u00e9rivaginales, cancers m\u00e9tastasiques et tumeurs malignes rares du col de l’ut\u00e9rus sont identifiables sur les frottis ThinPrep\u00ae<\/sup>. L’\u00e9tablissement d’un diagnostic d\u00e9finitif n\u00e9cessite parfois la connaissance des ant\u00e9c\u00e9dents de la patiente et l’utilisation de colorations sp\u00e9ciales, mais le processus malin doit \u00eatre \u00e9vident.<\/p>\n

<\/a><\/p>\n

Rappel : Vous pouvez cliquer sur une image
\nde l’Atlas pour la voir dans un format plus grand.<\/strong><\/p>\n

\n\"Image<\/a><\/p>\n
Ad\u00e9nocarcinome ovarien
\n<\/strong>
\nPr\u00e9sence de m\u00e9tastases dans le vagin.
\n60X<\/div>\n<\/div>\n
Ad\u00e9nocarcinome ovarien
\n<\/strong>
\nPr\u00e9sence de m\u00e9tastases dans le vagin.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
Carcinome colique
\n<\/strong>
\nPr\u00e9sence de m\u00e9tastases dans le col de l’ut\u00e9rus et le vagin.
\n60X<\/div>\n<\/div>\n
Carcinome colique
\n<\/strong>
\nPr\u00e9sence de m\u00e9tastases dans le col de l’ut\u00e9rus et le vagin.
\n60X<\/div>\n<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
Carcinosarcome
\n<\/strong>
\nPr\u00e9sence d’\u00e9l\u00e9ments glandulaires n\u00e9oplasiques et de d\u00e9bris n\u00e9crotiques permettant d’\u00e9tablir un diagnostic de carcinosarcome.
\n60X<\/div>\n<\/div>\n
Carcinosarcome
\n<\/strong>
\nPr\u00e9sence d’\u00e9l\u00e9ments glandulaires n\u00e9oplasiques et de d\u00e9bris n\u00e9crotiques permettant d’\u00e9tablir un diagnostic de carcinosarcome.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
Ad\u00e9nocarcinome endom\u00e9trial
\n<\/strong>
\nPr\u00e9sence de m\u00e9tastases dans le vagin.
\n60X<\/div>\n<\/div>\n
Ad\u00e9nocarcinome endom\u00e9trial
\n<\/strong>
\nPr\u00e9sence de m\u00e9tastases dans le vagin.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
Tumeur mixte m\u00e9sodermique maligne
\n<\/strong>
\nTumeur de l’endom\u00e8tre avec groupes de cellules glandulaires malignes. \u00c9l\u00e9ments stromaux (cartilage) d\u00e9tect\u00e9s gr\u00e2ce \u00e0 la biopsie.
\n60X<\/div>\n<\/div>\n
Tumeur mixte m\u00e9sodermique maligne
\n<\/strong>
\nTumeur de l’endom\u00e8tre avec groupes de cellules glandulaires malignes. \u00c9l\u00e9ments stromaux (cartilage) d\u00e9tect\u00e9s gr\u00e2ce \u00e0 la biopsie.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
M\u00e9lanome malin<\/strong>
\nDans le col de l’ut\u00e9rus.
\n60X<\/div>\n<\/div>\n
M\u00e9lanome malin<\/strong>
\nDans le col de l’ut\u00e9rus.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
Ad\u00e9nocarcinome canalaire
\n<\/strong>
\nPr\u00e9sence de m\u00e9tastases dans le sein.
\n60X<\/div>\n<\/div>\n
Ad\u00e9nocarcinome canalaire
\n<\/strong>
\nPr\u00e9sence de m\u00e9tastases dans le sein.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
Carcinome de type transitionnel
\n<\/strong>
\nCancer uroth\u00e9lial, m\u00e9tastases dans la vessie.
\n60X<\/div>\n<\/div>\n
Carcinome de type transitionnel
\n<\/strong>
\nCancer uroth\u00e9lial, m\u00e9tastases dans la vessie.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
SCC
\n<\/strong>
\nDe la vulve.
\n60X<\/div>\n<\/div>\n
SCC
\n<\/strong>
\nDe la vulve.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
Ad\u00e9nocarcinome endocervical<\/strong>
\nLarge psammome associ\u00e9 \u00e0 un cas d’ad\u00e9nocarcinome dans le col de l’ut\u00e9rus.
\n60X<\/div>\n<\/div>\n
Ad\u00e9nocarcinome endocervical<\/strong>
\nLarge psammome associ\u00e9 \u00e0 un cas d’ad\u00e9nocarcinome dans le col de l’ut\u00e9rus.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
Lymphome<\/strong>
\nDu col de l’ut\u00e9rus.
\n60X<\/div>\n<\/div>\n
Lymphome<\/strong>
\nDu col de l’ut\u00e9rus.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
Lymphome<\/strong>
\nDu vagin.
\n60X<\/div>\n<\/div>\n
Lymphome<\/strong>
\nDu vagin.
\n60X<\/div>\n
<\/div>\n

\n\"Image<\/a><\/p>\n
Sarcome stromal endom\u00e9trial<\/strong>
\n60x<\/div>\n<\/div>\n
Sarcome stromal endom\u00e9trial<\/strong>
\n60x<\/div>\n
<\/div>\n

Retour au d\u00e9but<\/a>[\/vc_column_text][\/vc_column][vc_column width=”1\/3″][vc_widget_sidebar sidebar_id=”consulting-right-sidebar”][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row 0=””][vc_column 0=”” offset=”vc_hidden-lg vc_hidden-md”][vc_raw_html 0=””]PGNlbnRlcj48YSBjbGFzcz0ic2hpZnRuYXYtdG9nZ2xlIHNoaWZ0bmF2LXRvZ2dsZS1idXR0b24iIGRhdGEtc2hpZnRuYXYtdGFyZ2V0PSJzaGlmdG5hdi1tYWluIj48aSBjbGFzcz0iZmEgZmEtYmFycyI+PC9pPiBUYWJsZSBvZiBDb250ZW50cyA8L2E+PC9jZW50ZXI+[\/vc_raw_html][\/vc_column][\/vc_row][vc_row][vc_column][vc_custom_heading text=”AUTRES N\u00c9OPLASMES MALINS, NOTAMMENT TUMEURS EXTRA-UT\u00c9RINES” font_container=”tag:h1|text_align:center” use_theme_fonts=”yes”][\/vc_column][\/vc_row][vc_row][vc_column width=”2\/3″][vc_column_text]AUTRES N\u00c9OPLASMES MALINS, NOTAMMENT TUMEURS EXTRA-UT\u00c9RINES Martha L. Hutchinson, MD, PhD Les tumeurs malignes p\u00e9rivaginales, cancers m\u00e9tastasiques et tumeurs malignes rares du col de l’ut\u00e9rus sont identifiables sur les frottis ThinPrep\u00ae. L’\u00e9tablissement d’un diagnostic d\u00e9finitif n\u00e9cessite parfois la connaissance des ant\u00e9c\u00e9dents<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":1888,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-1929","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/dev.cytologystuff.com\/fr\/wp-json\/wp\/v2\/pages\/1929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.cytologystuff.com\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dev.cytologystuff.com\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dev.cytologystuff.com\/fr\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.cytologystuff.com\/fr\/wp-json\/wp\/v2\/comments?post=1929"}],"version-history":[{"count":0,"href":"https:\/\/dev.cytologystuff.com\/fr\/wp-json\/wp\/v2\/pages\/1929\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/dev.cytologystuff.com\/fr\/wp-json\/wp\/v2\/pages\/1888"}],"wp:attachment":[{"href":"https:\/\/dev.cytologystuff.com\/fr\/wp-json\/wp\/v2\/media?parent=1929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}